Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn’s disease

References

• McPhillipsAWolfordLMRodriguesDBSAPHO syndrome with TMJ involvement: review of the literature and case presentationInt J Oral Maxillofac Surg201039121160116720832246
   PubMed Web of Science ®Google Scholar
• TakigawaTTanakaMNakanishiKSAPHO syndrome associated spondylitisEur Spine J200817101391139718642032
   PubMed Web of Science ®Google Scholar
• RukavinaISAPHO syndrome: a reviewJ Child Orthop201591192725585872
   PubMedGoogle Scholar
• GarcovichSAmeliaRMagarelliNValenzaVAmerioPLong-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literatureAm J Clin Dermatol2012131555922007948
   PubMed Web of Science ®Google Scholar
• WollinaUHanselGKochASchönlebeJKöstlerEHaroskeGTumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patientsAm J Clin Dermatol20089111418092839
   PubMed Web of Science ®Google Scholar
• IborraMBeltránBBastidaGAquasMNosPInfliximab and adalimumab-induced psoriasis in Crohn’s disease: a paradoxical side effectJ Crohns Colitis20115215716121453886
   PubMed Web of Science ®Google Scholar
• GuerraIPérez-JeldresTIborraMIncidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort studyInflamm Bowel Dis201622489490126933750
   PubMed Web of Science ®Google Scholar
• ZweegersJRoosenboomBvan de KerkhofPCFrequency and predictors of a high clinical response in psoriasis patients on biologic therapy in daily practiceBr J Dermatol2017176378679327454758
   PubMed Web of Science ®Google Scholar
• ChamotAMBenhamouCLKahnMFBeraneckLKaplanGProstALe syndrome acné pustulose hyperostose ostéïte (SAPHO). Réultats d’une enquête nationale: 85 observations. [Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey – 85 cases]Rev Rhum Mal Osreoartic1987543187196 French
   PubMedGoogle Scholar
• BenhamouCLChamotMLKahnMFSynovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO): a new syndrome among the spondyloarthropathies?Clin Exp Rheumatol1988621091122972430
   PubMed Web of Science ®Google Scholar
• Hurtado-NedelecMChollet-MartinSNicaise-RolandPCharacterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndromeRheumatology (Oxford)20084781160116718559374
   PubMed Web of Science ®Google Scholar
• AssmannGSimonPThe SAPHO syndrome: are microbes involved?Best Pract Res Clin Rheumatol201125342343422100290
   PubMed Web of Science ®Google Scholar
• BurgemeisterLTBaetenDLTasSWBiologics for rare inflammatory diseases: TNF blockade in the SAPHO syndromeNeth J Med2012701044444923230013
   PubMed Web of Science ®Google Scholar
• DenadaiRTeixeiraFVSteinwurzFRomitiRSaad-HossbeRInduction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 casesJ Crohns Colitis20137751752422960136
   PubMed Web of Science ®Google Scholar
• NguyenMTBorchersASelmiCNaguwaSMCheemaGGershwinMEThe SAPHO syndromeSemin Arthritis Rheum201242325426523153960
   PubMed Web of Science ®Google Scholar
• NavesJECabréEMaňosaMGradosDOlivéADomènechEA systematic review of SAPHO syndrome and inflammatory bowel disease associationDig Dis Sci20135882138214723543087
   PubMed Web of Science ®Google Scholar
• FiorinoGAllezMMalesciADaneseSReview article: anti TNF-α induced psoriasis in patients with inflammatory bowel diseaseAliment Pharmacol Ther200929992192719210297
   PubMed Web of Science ®Google Scholar
• SeversGALawlorTHPurcellSMAdlerJAThompsonRCutaneous adverse reaction to infliximab: report of psoriasis developing 3 patientsCutis200780323123717956013
   PubMed Web of Science ®Google Scholar
• PeramiquelLPuigLDalmauJRicartERoeEAlomarAOnset of flexural psoriasis during infliximab treatment for Crohn’s diseaseClin Exp Dermatol20053071371416197398
   PubMed Web of Science ®Google Scholar
• PirardDArcoDDebrouckereVHeenenMAnti-tumor necrosis factor α-induced psoriasiform eruptions: three further cases and current overviewDermatology2006213318218617033165
   PubMed Web of Science ®Google Scholar
• TakahashiHHashimotoYIshida-YamamotoAAshidaTKohgoYIizukaHPsoriasiform and pustular eruption induced by infliximabJ Dermatol200734746847217584325
   PubMed Web of Science ®Google Scholar
• UmenoJMatsumotoTJoYIchikawaMUrabeKIidaMPsoriasis during anti-tumor necrosis factor-α therapy for Crohn’s diseaseInflamm Bowel Dis20071391188118917427237
   PubMed Web of Science ®Google Scholar
• SladdenMJClarkePJWettenhallJInfliximab-induced palmoplantar pustulosis in a patient with Crohn diseaseArch Dermatol2007143111449
   Google Scholar
• EnglishPLVenderROccurrence of plantar pustular psoriasis during treatment with infliximabJ Cutan Med Surg2009131404219298770
   PubMed Web of Science ®Google Scholar
• ManniEBarachiniPPsoriasis induced by infliximab in a patient suffering from Crohn’s diseaseInt J Immunopathol Pharmacol200922384184419822070
   PubMed Web of Science ®Google Scholar
• MedkourFBabaiSChanteloupEBuffardVDelchierJCLe-LouetHDevelopment of diffuse psoriasis with alopecia during treatment of Crohn’s disease with infliximabGastroenterol Clin Biol201034214014120138448
   PubMedGoogle Scholar
• El Shabrawi-CaelenLLa PlacaMVincenziCHaidnTMuelleggerRTostiAAdalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-α blockersInflamm Bowel Dis201016218218319462433
   PubMed Web of Science ®Google Scholar
• CohenJDBourneriasIBuffardVPsoriasis induced by tumor necrosis factor-α antagonist therapy: a case seriesJ Rheumatol200734238038517013997
   PubMed Web of Science ®Google Scholar
• ThurberMFeaselAStroehleinJHymesSRPustular psoriasis induced by infliximabJ Drugs Dermatol20043443944015303790
   PubMedGoogle Scholar
• AllisonMCDhillonAPLewisWGPounderREInflammatory Bowel DiseaseLondonMosby1998
   Google Scholar
• ChoJHBrantSRRecent insights into the genetics of inflammatory bowel diseaseGastroenterology201114061704171221530736
   PubMed Web of Science ®Google Scholar
• ToussirotEAubinFParadoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overviewRMD Open201622e00023927493788
   PubMed Web of Science ®Google Scholar